TSCM肿瘤干细胞成球培养基-无血清

球体培养无需支架，通过贴壁细胞趋向于聚集的特性形成细胞球体，可观察肿瘤的发生，维持肿瘤体基本特征，是用于 3D 细胞培养的最常见、最通用的无支架方法之一，常用的球体包括胚胎小体、乳腺球、肿瘤球体、肝细胞球和神经球，用于CSC研究。此款培养基不含血清，由干细胞生长重组蛋白，维生素，矿物质等组成，添加小分子化合物AMP,BMP inhibitor，Rock及SMOC-2 等抑制杂细胞生长并促进肿瘤干细胞以及恶性细胞株成瘤。

培养基优势：

1. 大部分肿瘤细胞株可直接使用TSCM成球

2.可培养复杂的球体和类器官

3.可维持同质肿瘤球的传代和扩增

4.无血清无直接动物源蛋白组分，可保持实验的统一性和可验证性。

培养基配方：

基础培养基：250ml (P2400) ，细胞生长因子（TSGCS）25ml (P2402)，G/A：2.5ml(SD0038）

备注：100ml瓶装无套件，为整瓶配制。

说明：产品仅科研使用

1. A nanotherapeutic system for gastric cancer suppression by synergistic chemotherapy and immunotherapy based on iPSCs and DCs exosomes.  Cancer Immunol Immunother 72, 1673–1683 (2023). 

https://doi.org/10.1007/s00262-022-03355-6

2. The ameliorative effect on chemotherapy-induced injury and tumor immunosuppressive microenvironment of the polysaccharide from the rhizome of Menispermum dauricum DC

https://doi.org/10.1016/j.ijbiomac.2024.131828

3. Xiaoli Wang, Yan Zhou, Xiaomin Lu, Lili Shao；Machine learning models reveal ARHGAP11A's impact on lymph node metastasis and stemness in NSCLC

published: 31 October 2024 https://doi.org/10.1002/biof.2141

4.Lei Shi，Jian Huang，Xifeng Fei，Bao He，Zhixiang Sun，guan sun，DMC-BH derivative DMC-GF inhibits the growth of glioma stem cells by targeting the TRIM33/SLC25A1/mitochondrial oxidative phosphorylation pathway，https://www.researchsquare.com/article/rs-5306321/v1

5.J. et al. DMC-BH derivative DMC-GF inhibits the growth of glioma stem cells by targeting the TRIM33/SLC25A1/mitochondrial oxidative phosphorylation pathway. J Transl Med 23, 363 (2025). https://doi.org/10.1186/s12967-025-06355-z